Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Kettenmann, Helmut Prof. Dr. (41) Kopp, Joachim Dr. (2) Krabbe, Grietje Dr. (1) Ku, Min-Chi Dr. (2) Maglione, Marta (1) Nolte, Christiane Dr. (1) Pezzutto, Antonio Prof. Dr. (4) Semtner, Marcus Dr. (1) Siffrin, Volker (2) Stein, Ulrike Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (2) Wolf, Susanne Dr. (12) (-) Blankenstein, Thomas Prof. Dr. (20) (-) Kammertöns, Thomas Dr. (4) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Uckert, Wolfgang Prof. Dr. (6) Biologie maligner Lymphome (11) Entwicklungsneurobiologie (1) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (21) Neuroimmunologie-Labor (1) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (4) (-) Zelluläre Neurowissenschaften (1) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (3) 2000 (10) 2001 (5) 2002 (5) 2003 (9) 2004 (9) 2005 (10) 2006 (1) 2007 (6) 2008 (6) 2009 (3) 2010 (7) (-) 2011 (6) 2012 (6) 2013 (11) (-) 2014 (3) (-) 2015 (4) 2016 (6) 2017 (6) 2018 (7) 2019 (7) 2020 (3) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 22 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Kammertöns, Thomas Dr.Leisegang, Matthias Prof. Dr. rer. nat.Uckert, Wolfgang Prof. Dr.Molekulare Immunologie und Gentherapie Zelluläre Neurowissenschaften1998201120142015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger 01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein 01. Januar 1998 / Gene Ther Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation J. Westermann A. Aicher Z. Qin S. Cayeux K. Daemen T. Blankenstein B. Doerken A. Pezzutto 01. Januar 1998 / Hum Gene Ther Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo W. Uckert T. Kammertoens K. Haack Z. Qin J. Gebert D.J. Schendel T. Blankenstein 04. Mai 1998 / J Exp Med Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels C. Lange T. Schueler T. Blankenstein 01. Januar 1998 / Nat Med B cells inhibit induction of T cell-dependent tumor immunity Z.H. Qin G. Richter T. Schueler S. Ibe X.T. Cao T. Blankenstein 01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen 01. September 1998 / J Immunol Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-11 M. Petersson J. Charo F. Salazar-Onfray G. Noffz M. Mohaupt Z.H. Qin G. Klein T. Blankenstein R. Kiessling 01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger
01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein
01. Januar 1998 / Gene Ther Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation J. Westermann A. Aicher Z. Qin S. Cayeux K. Daemen T. Blankenstein B. Doerken A. Pezzutto
01. Januar 1998 / Hum Gene Ther Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo W. Uckert T. Kammertoens K. Haack Z. Qin J. Gebert D.J. Schendel T. Blankenstein
04. Mai 1998 / J Exp Med Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels C. Lange T. Schueler T. Blankenstein
01. Januar 1998 / Nat Med B cells inhibit induction of T cell-dependent tumor immunity Z.H. Qin G. Richter T. Schueler S. Ibe X.T. Cao T. Blankenstein
01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
01. September 1998 / J Immunol Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-11 M. Petersson J. Charo F. Salazar-Onfray G. Noffz M. Mohaupt Z.H. Qin G. Klein T. Blankenstein R. Kiessling
01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken